Morphinan N-Demethylase Enzyme for Opiate Conversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for N-demethylation of opiates are chemical in nature, requiring toxic reagents and having low yields, with enzymatic approaches not being widely described or utilized.

Innovation Solution

The use of a morphinan N-demethylase enzyme (MND) identified from Methylobacterium Thebainfresser, which can efficiently convert N-methylated compounds into their N-demethylated forms, eliminating the need for toxic chemicals and improving yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chemical reagents are used for N-demethylation, then the reaction can proceed, but toxic and expensive reagents are required and yield is low

Engineering Contradiction:
ImproveyieldVSAvoidtoxic reagents
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces chemical reagents with an enzymatic system (morphinan N-demethylase from Methylobacterium Thebainfresser) to catalyze the N-demethylation reaction. This substitution eliminates the need for toxic chemical reagents while achieving high conversion yields, directly resolving the contradiction between productivity and harmful factors.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the reaction conditions from chemical parameters (reagent concentration, temperature, pH) to enzymatic parameters (enzyme activity, cofactor presence, substrate concentration). This parameter transformation enables the reaction to proceed under milder, non-toxic conditions while maintaining or improving yield.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If chemical N-demethylation methods are used, then the transformation can be achieved, but the methods are low in yield and require expensive reagents

Engineering Contradiction:
ImproveyieldVSAvoidcost of reagents
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent substitutes expensive chemical reagents with a biologically derived enzyme system. The morphinan N-demethylase can be produced through fermentation of Methylobacterium Thebainfresser, making the process more cost-effective while simultaneously improving yield through enzymatic catalysis efficiency.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The bacterium Methylobacterium Thebainfresser naturally produces the demethylase enzyme as part of its metabolic pathway for utilizing thebaine. This self-service capability of the organism eliminates the need for external expensive reagents, as the system generates its own catalytic agent through microbial growth and metabolism.

Inventive Principle:
Principle #25Self-service

3Productivity

If traditional chemical methods are used for N-demethylation, then the process is well-established, but the methods are not environmentally clean and have low efficiency

Engineering Contradiction:
Improveconversion efficiencyVSAvoidchemical waste
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent replaces chemical catalysis with enzymatic catalysis, where the morphinan N-demethylase selectively converts N-methylated compounds to their demethylated forms. This substitution improves conversion efficiency through specific enzyme-substrate recognition while minimizing harmful chemical waste generation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent utilizes the natural metabolic capability of Methylobacterium Thebainfresser to convert thebaine (a toxic alkaloid) into northebaine through enzymatic demethylation. The bacterium's natural pathway, originally evolved for detoxification or metabolism, is harnessed to convert a harmful substance into a useful intermediate for pharmaceutical synthesis.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This enzymatic method achieves high conversion rates of N-methylated compounds to their demethylated forms, such as thebaine to northebaine, with the MND enzyme demonstrating broad substrate activity and stability across various conditions, offering a cleaner and more efficient alternative to traditional chemical methods.

Implementation Method 1

enzymatic N-demethylation has not been widely described

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

The N-demethylation of such opiates is a key chemical transformation in the synthesis of synthetic opiates

Methodology Applied
Scientific EffectN-demethylation reaction: Chemical Bonding

Data Source

PatentUS11542481B2Morphinan N-demethylase isolated from the methylobacterium thebainfresser and methods of use thereof
Publication Date: 2023.01.03 DONALD DANFORTH PLANT SCI CENT
  • US11542481B2 patent drawing
  • US11542481B2 patent drawing
  • US11542481B2 patent drawing

AI summary

Disclosed herein are methods for N-demethylating an N-methylated compound using an enzymatic reaction, rather than, e.g. a chemical modification. Also provided herein are enzymes for performing the reaction.